435P Development of PF-06439535, a potential biosimilar to...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

435P Development of PF-06439535, a potential biosimilar to bevacizumab

Jacobs, I.A., Brown, P.R., Knight, B., Peraza, M.A., Rosenberg, J.A., Rule, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw593.005
Date:
December, 2016
File:
PDF, 38 KB
english, 2016
Conversion to is in progress
Conversion to is failed